In the final model for stage I adenocarcinomas, SerpinB2 retained independent prognostic value for LCSS (HR 2.6 (95 % CI 1.03-6.58), p = 0.043) (Supplementary Table 10A). Here, SERPINB2 is linked to adenocarcinoma.